Login / Signup

Use of medium chain triglyceride (MCT) oil in subjects with Alzheimer's disease: A randomized, double-blind, placebo-controlled, crossover study, with an open-label extension.

Angela G JubyToni E BlackburnDiana R Mager
Published in: Alzheimer's & dementia (New York, N. Y.) (2022)
This is the longest duration MCT AD study to date. Eighty percent had stabilization or improvement in cognition, and better response with 9-month continual MCT oil.
Keyphrases
  • placebo controlled
  • double blind
  • clinical trial
  • fatty acid
  • study protocol
  • phase ii
  • phase iii
  • white matter
  • randomized controlled trial
  • rectal cancer